Amanda Binkley, PharmD, AAHIVP

home / authors / amanda-binkley-pharmd-aahivp

Articles

Site Logo

Treatment as Prevention: A Comprehensive Approach to Hepatitis C Virus in Persons Who Inject Drugs

Amanda Binkley, PharmD, AAHIVP
August 9th 2017

With IV drug use accounting for 60% of new infections, treatment for individuals in this population is necessary to stave off new infections.

Read More

Site Logo

Preventing Clostridium difficile From Getting Loose

Amanda Binkley, PharmD, AAHIVP;Shawn Binkley, BS, PharmD
May 10th 2017

What can healthcare providers do to stop these infections before they start?

Read More

Site Logo

Epclusa: What Have We Learned?

Amanda Binkley, PharmD, AAHIVP;Ashley Sheridan, PharmD
January 2nd 2017

Read More

Latest Updated Articles

Concerns Over Mosquito-Borne Illness Causes Massachusetts Town to Create Curfew for Parks, Spraying in Counties
Published: August 27th 2024 | Updated: August 28th 2024
Concerns Over Mosquito-Borne Illness Causes Massachusetts Town to Create Curfew for Parks, Spraying in Counties
Two Years After its FDA Approval, Rebyota Continues to Show Efficacy and Safety
Published: November 18th 2024 | Updated: November 22nd 2024
Two Years After its FDA Approval, Rebyota Continues to Show Efficacy and Safety
Imdusiran for Chronic Hepatitis B Achieves Functional Cure in 50% of Patients
Published: November 18th 2024 | Updated: November 22nd 2024
Imdusiran for Chronic Hepatitis B Achieves Functional Cure in 50% of Patients
Challenges of Treating Patients With Staphylococcus aureus
Published: November 18th 2024 | Updated: November 22nd 2024
Challenges of Treating Patients With Staphylococcus aureus
STAY PrEPARED: Understanding COVID-19 Pre-Exposure Prophylaxis
Published: November 10th 2024 | Updated: November 22nd 2024
STAY PrEPARED: Understanding COVID-19 Pre-Exposure Prophylaxis
Echinocandin Dosing Considerations in Obese Patients: A Review
Published: November 18th 2024 | Updated: November 18th 2024
Echinocandin Dosing Considerations in Obese Patients: A Review
© 2024 MJH Life Sciences

All rights reserved.